← Evidence map

ArticlePharmacological research2020

Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system.

Shuofeng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

50 papers cite it

2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32473310